STVN — Stevanato Group S.p.A.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1849853 · Italy
Last close
$17.97
Market Cap
$893.28M
52W High
$19.05
52W Low
$12.89
ADV30
510,142
Next earnings
2026-08-04
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 273,574,000 75,178,000 38,737,000 28,029,000 2,583,821,000 111,670,000 1,052,995,000
Dec 2025 346,482,000 106,899,000 70,084,000 47,555,000 2,543,974,000 130,603,000 1,057,453,000
Sep 2025 303,167,000 88,500,000 52,721,000 36,064,000 2,414,007,000 113,333,000 976,721,000
Jun 2025 280,000,000 78,600,000 41,400,000 29,700,000 2,351,100,000 94,200,000 953,200,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$261,728,000
Investing CF
$-272,608,000
Financing CF
$32,881,000
CapEx
$-273,964,000
Dividends Paid
$-14,457,000
Buybacks
EPS Diluted TTM
$0.51
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,019,614,000
Inventory
$294,360,000
Receivables
$506,659,000
ST Investments
$1,064,000
EBIT TTM
$209,266,000
Pretax Income TTM
$193,228,000
Interest Exp TTM
$16,038,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,203,260,032
EBITDA
$288,579,008
Free Cash Flow
$-57,059,124
Enterprise Value
$5,255,140,352
Total Cash
$112,276,000
Total Debt
$450,584,000
Shares Out
49,709,718
Trailing EPS
$0.59
Book Value
$6.37
ROE
9.6%
ROA
5.3%
Div Yield
0.35%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,186,282,000 198,801,000 139,839,000 2,543,974,000 1,057,453,000 286,077,000
Dec 2024 1,104,036,000 161,142,000 117,778,000 2,328,819,000 924,434,000 155,776,000
Dec 2023 1,085,354,000 200,720,000 145,631,000 2,071,577,000 938,931,000 105,210,000
Dec 2022 983,680,000 192,431,000 142,849,000 1,659,698,000 663,788,000 103,312,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.85

Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $17.50 · spot: $17.97 · call volume: 15 · put volume: 26
Expected Move to 2026-06-18: ±$5.30 (29.49%) — implied range $12.67$23.27 · ATM straddle on $17.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
AVR Anteris Technologies Global Corp. $883.87M $9.08
DRTS Alpha Tau Medical Ltd. $936.68M $10.37
INMD InMode Ltd. $839.77M $13.81
TNDM TANDEM DIABETES CARE INC $996.41M $14.54
BFLY Butterfly Network, Inc. $1.07B $4.54

News headlines (Yahoo Finance, 1h cache)

Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
2026-05-09 14:02 · Yahoo
Stevanato (STVN) Q1 2026 Earnings Transcript
2026-05-08 15:58 · Yahoo
Stevanato Group S.p.A. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
2026-05-07 11:45 · Yahoo
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
2026-05-07 10:30 · Yahoo
A Look At Stevanato Group’s (NYSE:STVN) Valuation After Its Recent Share Price Rebound
2026-05-07 09:19 · Yahoo
Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates
2026-05-06 12:25 · Yahoo
Stevanato Group to Participate in Three Upcoming Investor Conferences
2026-05-04 21:45 · Yahoo
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
2026-05-04 14:00 · Yahoo
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
2026-04-30 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.